Compare IDE & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDE | INGN |
|---|---|---|
| Founded | 2010 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.9M | 190.9M |
| IPO Year | N/A | 2014 |
| Metric | IDE | INGN |
|---|---|---|
| Price | $13.22 | $6.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 33.5K | ★ 181.4K |
| Earning Date | 01-01-0001 | 02-24-2026 |
| Dividend Yield | ★ 8.83% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $347,028,000.00 |
| Revenue This Year | N/A | $8.04 |
| Revenue Next Year | N/A | $8.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.68 |
| 52 Week Low | $8.61 | $5.70 |
| 52 Week High | $10.46 | $12.91 |
| Indicator | IDE | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 89.34 | 41.49 |
| Support Level | $12.33 | $6.11 |
| Resistance Level | $13.26 | $6.54 |
| Average True Range (ATR) | 0.12 | 0.28 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 97.04 | 22.60 |
Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.